184 related articles for article (PubMed ID: 16619516)
1. Combination effect of TZT-1027 (Soblidotin) with other anticancer drugs.
Natsume T; Watanabe J; Horiuchi T; Kobayashi M
Anticancer Res; 2006; 26(2A):1145-51. PubMed ID: 16619516
[TBL] [Abstract][Full Text] [Related]
2. Antitumor activity of TZT-1027, a novel dolastatin 10 derivative.
Kobayashi M; Natsume T; Tamaoki S; Watanabe J; Asano H; Mikami T; Miyasaka K; Miyazaki K; Gondo M; Sakakibara K; Tsukagoshi S
Jpn J Cancer Res; 1997 Mar; 88(3):316-27. PubMed ID: 9140117
[TBL] [Abstract][Full Text] [Related]
3. Antitumor activity of TZT-1027 (Soblidotin) against vascular endothelial growth factor-secreting human lung cancer in vivo.
Natsume T; Watanabe J; Koh Y; Fujio N; Ohe Y; Horiuchi T; Saijo N; Nishio K; Kobayashi M
Cancer Sci; 2003 Sep; 94(9):826-33. PubMed ID: 12967483
[TBL] [Abstract][Full Text] [Related]
4. [Antitumor activity of combination treatment combining gemcitabine with topotecin against human lung cancer xenografted in nude mice].
Fujita F; Koike M; Fujita M
Gan To Kagaku Ryoho; 2002 Apr; 29(4):577-84. PubMed ID: 11977542
[TBL] [Abstract][Full Text] [Related]
5. [Current perspectives of new agents in lung cancer].
Fukuoka M
Nihon Rinsho; 2000 May; 58(5):1103-10. PubMed ID: 10824557
[TBL] [Abstract][Full Text] [Related]
6. Perspectives and opportunities: Docetaxel in the current and future treatment of non-small cell lung cancer.
Green MR
Semin Oncol; 2002 Jun; 29(3 Suppl 12):17-21. PubMed ID: 12170447
[TBL] [Abstract][Full Text] [Related]
7. Non-platinum based combination chemotherapy: phase I and II trials of docetaxel plus gemcitabine, vinorelbine, or irinotecan.
Rigas JR
Semin Oncol; 2001 Jun; 28(3 Suppl 9):15-20. PubMed ID: 11441410
[TBL] [Abstract][Full Text] [Related]
8. Challenging the platinum combinations in the chemotherapy of NSCLC.
Douillard JY; Eckardt J; Scagliotti GV
Lung Cancer; 2002 Dec; 38 Suppl 4():21-8. PubMed ID: 12480191
[TBL] [Abstract][Full Text] [Related]
9. Continuous inhibition of epidermal growth factor receptor phosphorylation by erlotinib enhances antitumor activity of chemotherapy in erlotinib-resistant tumor xenografts.
Iwai T; Moriya Y; Shirane M; Fujimoto-Ouchi K; Mori K
Oncol Rep; 2012 Apr; 27(4):923-8. PubMed ID: 22209766
[TBL] [Abstract][Full Text] [Related]
10. [Developed new agents for lung cancer].
Kato Y; Saijo N
Nihon Geka Gakkai Zasshi; 2002 Feb; 103(2):218-23. PubMed ID: 11904983
[TBL] [Abstract][Full Text] [Related]
11. Irinotecan plus gemcitabine vs irinotecan for the second-line treatment of patients with advanced non-small-cell lung cancer pretreated with docetaxel and cisplatin: a multicentre, randomised, phase II study.
Georgoulias V; Kouroussis C; Agelidou A; Boukovinas I; Palamidas P; Stavrinidis E; Polyzos A; Syrigos K; Veslemes M; Toubis M; Ardavanis A; Tselepatiotis E; Vlachonikolis I;
Br J Cancer; 2004 Aug; 91(3):482-8. PubMed ID: 15238986
[TBL] [Abstract][Full Text] [Related]
12. [Outpatient chemotherapy for lung cancer].
Yoneda S
Gan To Kagaku Ryoho; 2007 Apr; 34(4):533-7. PubMed ID: 17431337
[TBL] [Abstract][Full Text] [Related]
13. [Chemotherapy for advanced non-small cell lung cancer].
Ueoka H
Gan To Kagaku Ryoho; 2005 Jun; 32(6):770-6. PubMed ID: 15984514
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapy in metastatic non-small-cell lung cancer.
Sandler A
Oncology (Williston Park); 2000 Jul; 14(7 Suppl 5):15-27. PubMed ID: 10981287
[TBL] [Abstract][Full Text] [Related]
15. Gemcitabine-based combination treatment of pancreatic cancer.
Heinemann V
Semin Oncol; 2002 Feb; 29(1 Suppl 3):25-35. PubMed ID: 11894005
[TBL] [Abstract][Full Text] [Related]
16. [New therapeutic approaches in non-small-cell lung carcinoma (NSCLC), stages IV].
Mavroudis D
Rev Pneumol Clin; 2001 Nov; 57(5 Pt 2):S42-5. PubMed ID: 11924243
[No Abstract] [Full Text] [Related]
17. A phase I-II study of bi-weekly gemcitabine and irinotecan as second-line chemotherapy in non-small cell lung cancer after prior taxane + platinum-based regimens.
Kosmas C; Tsavaris N; Syrigos K; Koutras A; Tsakonas G; Makatsoris T; Mylonakis N; Karabelis A; Stathopoulos GP; Kalofonos HP
Cancer Chemother Pharmacol; 2007 Jan; 59(1):51-9. PubMed ID: 16622691
[TBL] [Abstract][Full Text] [Related]
18. In vitro simulation study of individualized chemotherapy in lung cancer.
Li C; Gemma A; Minegishi Y; Matsuda K; Seike Y; Noro R; Shionoya A; Kawakami A; Ogawa N; Kudoh S
J Nippon Med Sch; 2007 Jun; 74(3):217-22. PubMed ID: 17625370
[TBL] [Abstract][Full Text] [Related]
19. Chemoradiation in locally advanced non-small cell lung cancer.
Bonomi P; Shirazi W
Cancer Treat Res; 2001; 105():171-88. PubMed ID: 11224987
[No Abstract] [Full Text] [Related]
20. Docetaxel/gemcitabine or cisplatin/gemcitabine followed by docetaxel in the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC): results of a multicentre randomized phase II trial.
Binder D; Schweisfurth H; Grah C; Schäper C; Temmesfeld-Wollbrück B; Siebert G; Suttorp N; Beinert T
Cancer Chemother Pharmacol; 2007 Jun; 60(1):143-50. PubMed ID: 17031643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]